Add to ORKGGnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospectiv
Aim: This study was designed to investigate the effects of gonadotropin-releasing hormone agonist (...
This is a prospective comparative study investigating cost and effectiveness of IVF/ intracytoplasmi...
Human chorionic gonadotropin (hCG) is no longer a single, omnipotent ovulation triggering option. Go...
Benefits of the short-term utilization of a gonadotropin-releasing hormone (GnRH) agonist (Buserelin...
New methods of ovulation induction have been discovered and perfected in recent years. Among others,...
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a...
AbstractFinal oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with ...
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intr...
This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered ei...
Background. The aim of this pilot study was to evaluate intranasal buserelin for luteal phase suppor...
Background: Gonadotropin-releasing hormone agonists (GnRH-a) was increasingly used for triggering oo...
GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomize
BACKGROUND: The aim of the study was to investigate whether intranasal (IN) administration of a GnRH...
Aim: This study was designed to investigate the effects of gonadotropin-releasing hormone agonist (G...
Ovulation induction is the method for treating anovulatory infertility. For patients with hypogonado...
Aim: This study was designed to investigate the effects of gonadotropin-releasing hormone agonist (...
This is a prospective comparative study investigating cost and effectiveness of IVF/ intracytoplasmi...
Human chorionic gonadotropin (hCG) is no longer a single, omnipotent ovulation triggering option. Go...
Benefits of the short-term utilization of a gonadotropin-releasing hormone (GnRH) agonist (Buserelin...
New methods of ovulation induction have been discovered and perfected in recent years. Among others,...
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a...
AbstractFinal oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with ...
Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intr...
This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered ei...
Background. The aim of this pilot study was to evaluate intranasal buserelin for luteal phase suppor...
Background: Gonadotropin-releasing hormone agonists (GnRH-a) was increasingly used for triggering oo...
GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomize
BACKGROUND: The aim of the study was to investigate whether intranasal (IN) administration of a GnRH...
Aim: This study was designed to investigate the effects of gonadotropin-releasing hormone agonist (G...
Ovulation induction is the method for treating anovulatory infertility. For patients with hypogonado...
Aim: This study was designed to investigate the effects of gonadotropin-releasing hormone agonist (...
This is a prospective comparative study investigating cost and effectiveness of IVF/ intracytoplasmi...
Human chorionic gonadotropin (hCG) is no longer a single, omnipotent ovulation triggering option. Go...